Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
463-06-009 ISMRM Abstract

Radiomic feature analyses reveal imaging biomarkers correlated with PI-RADS lesion classification in prostate cancer MRI.

Primary: Body - Prostate
Secondary: Analysis Methods - Radiomics
463-06-009 · Image Analysis for Cancer · Tuesday, 12 May, 4:55 PM–5:50 PM · Digital Posters Row D
Keywords: Radiomics Prostate MRI Radiomics analysis Prostate Imaging Reporting and Data System Prostate cancer (PCa)
Accepted
Savannah R Duenweg 1, Michael J Barrett1, Samuel Bobholz1, Allison Lowman1, Biprojit Nath2, Aleksandra Winiarz2, Hope M Reecher1, Fitzgerald Kyereme1, Stephanie Vincent-Sheldon1, Kathleen Bhatt1, Katherine Troy1, Michael Kim1, Eric Fair1, William A Hall3, Peter S LaViolette1,2,4
1Radiology, Medical College of Wisconsin, Milwaukee, United States of America
2Biophysics, Medical College of Wisconsin, Milwaukee, United States of America
3Radiation Oncology, Medical College of Wisconsin, Milwaukee, United States of America
4Biomedical Engineering, Medical College of Wisconsin, Milwaukee, United States of America
Presenting Author: Savannah R Duenweg

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. doi:10.3322/caac.21820 [doi]
2. Gillies RJ, Schabath MB. Radiomics Improves Cancer Screening and Early Detection. Cancer Epidemiol Biomarkers Prev. Dec 2020;29(12):2556-2567. doi:10.1158/1055-9965.EPI-20-0075 [doi]
3. Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, Stebbins M, Bukowy J, Iczkowski KA, Jacobsohn KM, Vincent-Sheldon S, LaViolette PS. T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers (Basel). 2023 Sep 6;15(18):4437. doi: 10.3390/cancers15184437. PMID: 37760407; PMCID: PMC10526331. [doi] [pmid]
4. Schoots IG. MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol. 2018 Feb;7(1):70-82. doi: 10.21037/tau.2017.12.31. PMID: 29594022; PMCID: PMC5861283. [doi] [pmid]
5. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ; European Society of Urogenital Radiology. ESUR prostate MR guidelines 2012. Eur Radiol. 2012 Apr;22(4):746-57. doi: 10.1007/s00330-011-2377-y. Epub 2012 Feb 10. PMID: 22322308; PMCID: PMC3297750. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/463-06-009